Discover the details of a case of crizotinib-induced esophageal ulcers in a 45-year-old woman with metastatic anaplastic lymphoma kinase-positive non-small-cell lung cancer after 10 weeks of therapy, in this case report.
Browsing: adverse effects
Data has demonstrated that a novel immunotherapy is generally well tolerated and exhibits preliminary evidence of anti-tumor activity in hepatocellular carcinoma patients.
In this commentary article from Future Oncology the authors explore the issues of erectile dysfunction and infertility in male cancer patients.
Owing to the wide variation in the incidence of toxicity in patients treated with sorafenib, this primary paper details a study investigating the potential role of genetic polymorphisms in the incidence of side effects.
Researchers have demonstrated that treatment with sodium thiosulfate significantly reduced cisplatin-induced hearing difficulties in children and adolescents with cancer.
A new study has produced an animal model useful for studying long-term cognitive deficits following chemotherapeutic treatment for breast cancer, and has confirmed the long-term effects of ‘chemobrain’.
Take a look at the most common side effects associated with checkpoint inhibitor therapy and explore the options for their management in this peer-reviewed article from Immunotherapy.
Risk factors, biomarkers and potential preventative strategies are dicussed in this review article on chemotherapy-induced cardiotoxicity in breast cancer patients.
A recent study reports that treating early stage lung cancer patients with stereotactic body radiation therapy could increase their risk of death from noncancer causes.
Check out our exclusive infographic to discover more about the Phase III MAGIC trial and the efficacy of APF530 for the treatment of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.